MTD

Mettler-Toledo International Inc.

HealthcareDiagnostics & ResearchNASDAQ

$1,180.58

+$97.58 (8.27%)today

Conviction

6/ 10

Fair Value$1,498.31

Upside+26.91%

Signal16.15

Market Cap$25.7B

52W Range$946.69–$1,525.17

Next EarningsApr 30

Conviction History

Conviction Changes

No conviction changes recorded

Premium Content

Upgrade to premium to see the full reasoning behind each conviction change.

Price History

FAIR VALUE ANALYSISMonte Carlo · 5,000 runs · 99% valid

Fair Value$372.34

Current Price$1204.48

Upside / Down-69.1%

P(Undervalued)0.0%

P(20%+ Up)0.0%

P(15%+ Down)100.0%

Fair Value Distribution — percentile bands

0.0% of simulations place fair value above current price

WHAT IS PRICED IN

Revenue-Based Reverse DCF

29.1%/yr

±4.8% · revenue growth to justify current price

FCF-Based Reverse DCF

28.8%/yr

±3.3% · FCF growth to justify current price

THE GAP

Market pricing margin expansion or capex normalization

Premium Content

Upgrade to premium for full distribution data, sensitivity analysis, and segment breakdowns.

Bull Case

Mettler-Toledo precision instruments; lab/industrial weighing; China recovery catalyst.

Bear Case

Lab capex caution; China slowdown risk; high valuation vs peers.

Updated Apr 7

Research Feed

sec_10kMar 3

Conviction: unchanged

MTD 2025 10-K: Tariffs Headwind But Execution Solid

MTD 2025: Revenue +4% USD but margin compression from tariffs (-50bps) and mix. Service strong. China soft post-COVID normalization. Management expects tariff offset in 2026 but visibility low. Pricin...